|
Muir-Torre Syndrome
|
C17.800.827.610 |
|
|
Immunoglobulins, Thyroid-Stimulating
|
D12.776.124.790.651.114.323.480 |
|
|
Chromosomes, Human, Pair 1
|
G05.360.162.520.300.235.240 |
|
|
Resins, Synthetic
|
J01.637.051.339.816 |
|
|
Chromosomes, Human, Pair 2
|
G05.360.162.520.300.235.245 |
|
|
Mandibular Nerve Injuries
|
C10.292.200.875.750 |
|
|
Tartrates
|
D02.241.081.844.759 |
|
|
Observational Studies as Topic
|
E05.318.372.250.500 |
|
|
Nitrogen Fixation
|
G03.087.630 |
|
|
Autotrophic Processes
|
G03.087 |
|
|
Honey
|
J02.500.581 |
|
|
Nectins
|
D12.776.395.550.200.123 |
|
|
Familial Exudative Vitreoretinopathies
|
C16.131.384.424 |
|
|
Ebolavirus
|
B04.820.480.937.300.200 |
|
|
Calcium Sulfate
|
D01.875.800.800.850.125 |
|
|
Intestinal Atresia
|
C16.131.314.466 |
|
|
Pregnancy-Associated alpha 2-Macroglobulins
|
D045384 |
[Large (>160 kDa) glycoproteins with electrophoretic mobility of ALPHA-GLOBULINS, found in high concentration in the plasma of pregnant women but also in a number of species including mouse, rat, and others (ALPHA-MACROGLOBULINS). In humans, they are always present in the circulation and are nonspecific inhibitors of PROTEINASES, similar to COMPLEMENT PROTEINS (C3; C4; C5).
] |
|
Omalizumab
|
D12.776.124.486.485.114.071.500 |
|
|
Antibodies, Anti-Idiotypic
|
D12.776.124.486.485.114.071 |
|
|
Meals
|
J02.500.590 |
|
